Author

Ivan Kungulovski

ORCID 0000-0001-6462-2587Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Goran KungulovskiiD· 2 shared Sanja Mehandziska· 2 shared Aleksandra Stajkovska· 1 shared Djansel BukoveciD· 1 shared Marija GjorgjievskaiD· 1 shared Marija Janevska· 1 shared Martina MarkovskaiD· 1 shared Milan RisteskiiD· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Goran KungulovskiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintOct 15, 2024

Tumors with mutations in chromatin regulators are associated with higher mutational burden and improved response to checkpoint immunotherapy

Goran Kungulovski, Marija Gjorgjievska, Sanja Mehandziska…·Zan Mitrev

This study shows that tumors with chromatin regulator mutations have higher mutational burden and better response to immunotherapy.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

GeneticsbioRxivPreprintDec 3, 2019

Genetic aberrations in chromatin factors are pervasive, mutually exclusive, associated with a high mutational burden and improved response to checkpoint immunotherapy in cancer

Martina Markovska, Rodney Alexander Rosalia, Aleksandra Stajkovska…·Goran Kungulovski

The paper examines genetic aberrations in chromatin modifiers across cancer datasets, finding mutual exclusivity, higher prevalence in certain cancers, and links to mutational burden and immunotherapy response.

DOI 10.1101/861823

humanwhole-genome sequencing

𝕏 PostBluesky